Mettler-Toledo International Inc. splits its revenue 2 ways in its filings. By operating segments, the largest line in fiscal 2025, which ended Dec 31, 2025 was US Operations at $1.5 billion, 37% of the total. By sales mix, the largest line in fiscal 2025, which ended Dec 31, 2025 was Laboratoryproductsandservices at $2.2 billion, 56% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Mar 31, 2026
|
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
FY 2020
Dec 31, 2020
|
FY 2019
Dec 31, 2019
|
FY 2013
Dec 31, 2013
|
FY 2012
Dec 31, 2012
|
FY 2011
Dec 31, 2011
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
—
|
4,026
|
3,872
|
3,788
|
3,920
|
3,718
|
3,085
|
3,009
|
2,379
|
2,342
|
2,309
|
| Operating segments | |||||||||||
| US Operations |
—
|
1,496
+4.7%
share 37.2%
|
1,430
+1.8%
share 36.9%
|
1,404
-2.8%
share 37.1%
|
1,444
+12.1%
share 36.9%
|
1,288
+20.1%
share 34.6%
|
1,072
+1.4%
share 34.8%
|
1,057
share 35.1%
|
—
|
—
|
—
|
| Western European Operations |
—
|
896
+4.4%
share 22.3%
|
858
+8.2%
share 22.2%
|
793
-0.9%
share 20.9%
|
800
-3.6%
share 20.4%
|
830
share 22.3%
|
—
|
701
share 23.3%
|
—
|
—
|
—
|
| Other Operations |
—
|
789
+6.9%
share 19.6%
|
738
+7.9%
share 19.1%
|
684
+4.0%
share 18.1%
|
658
+0.1%
share 16.8%
|
657
+14.5%
share 17.7%
|
574
+1.2%
share 18.6%
|
567
share 18.8%
|
—
|
—
|
—
|
| Chinese Operations |
—
|
635
+1.0%
share 15.8%
|
628
-12.6%
share 16.2%
|
719
-14.6%
share 19.0%
|
842
+9.1%
share 21.5%
|
772
+33.4%
share 20.8%
|
579
+6.2%
share 18.8%
|
545
share 18.1%
|
—
|
—
|
—
|
| Swiss Operations |
—
|
211
-3.5%
share 5.2%
|
219
+15.8%
share 5.6%
|
189
+7.1%
share 5.0%
|
176
+2.6%
share 4.5%
|
172
+19.3%
share 4.6%
|
144
+3.2%
share 4.7%
|
139
share 4.6%
|
—
|
—
|
—
|
| Sales mix | |||||||||||
| Laboratoryproductsandservices |
—
|
2,241
+2.5%
share 55.7%
|
2,186
+5.7%
share 56.5%
|
2,069
-7.2%
share 54.6%
|
2,230
+7.1%
share 56.9%
|
2,083
+24.7%
share 56.0%
|
1,670
+5.8%
share 54.1%
|
1,579
share 52.5%
|
—
|
—
|
—
|
| Industrialproductsandservices |
—
|
1,579
+6.0%
share 39.2%
|
1,490
-0.0%
share 38.5%
|
1,490
-1.3%
share 39.3%
|
1,511
+4.4%
share 38.5%
|
1,447
+18.1%
share 38.9%
|
1,224
-0.8%
share 39.7%
|
1,234
share 41.0%
|
—
|
—
|
—
|
| Retailproductsandservices |
—
|
206
+4.9%
share 5.1%
|
196
-14.3%
share 5.1%
|
229
+28.1%
share 6.0%
|
179
-5.1%
share 4.6%
|
188
-1.3%
share 5.1%
|
191
-2.6%
share 6.2%
|
196
share 6.5%
|
—
|
—
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Listed as
- MTD (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Columbus, OH
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1037646
- Former names
- MT INVESTORS INC/ (until Feb 13, 1998); METTLER TOLEDO INTERNATIONAL INC (until Nov 17, 1997); MT INVESTORS INC (until Nov 10, 1997)
Other Laboratory Analytical Instruments companies
- Agilent Technologies, Inc. A
- Waters Corp /DE/ WAT
- Illumina, Inc. ILMN
- Revvity, Inc. RVTY
- Avantor, Inc. AVTR
- Bio-Rad Laboratories, Inc. BIO
- Bruker Corp BRKR
- 10x Genomics, Inc. TXG
Source: SEC EDGAR filings. This is company-reported data, not investment advice.